ALFA Finder
India's fastest NSE & BSE filing alerts on Telegram, filtered to the stocks you hold
Telegram alerts
alfafinder.com →
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
50 announcements with these filters
Indo Borax & Chemicals Ltd reported revenue from operations of ₹58.9 Cr (+1.9% YoY) and net profit of ₹4.7 Cr (-71.2% YoY) for Q2 FY27.
Indo Borax pledged 14% of Kronox Lab Sciences shares as security for a ₹225 crore term loan. Kronox remains its subsidiary.
Indo Borax & Chemicals will hold a board meeting on 6 November 2026 to approve unaudited standalone and consolidated results for the quarter and half-year ended 30 September 2026. Trading window remains closed until 48 hours after results.
Indo Borax & Chemicals amended its Share Purchase Agreement dated August 20, 2026, by removing lock-in restrictions and the right of first refusal. This amendment clarifies promoter status.
Indo Borax & Chemicals Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Indo Borax created a pledge over 14% of subsidiary Kronox's shares to secure a ₹225 crore term loan. The pledge does not alter the company's control of the subsidiary.
Indo Borax & Chemicals Ltd issued a notice of postal ballot to seek shareholder approval for creating security on borrowings up to Rs. 400 Crore. Voting will occur via remote e-voting.
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited for ₹246.12 Crore.
Indo Borax & Chemicals Limited has completed the acquisition of a 64.26% stake in Kronox Lab Sciences Limited. The transaction involved purchasing 2,38,44,000 equity shares via a share purchase agreement.
Indo Borax & Chemicals Ltd has availed funding of ₹225 Crore from a lending institution. The capital will finance its acquisition of equity shares in Kronox Lab Sciences Limited.
Indo Borax & Chemicals reported postal ballot results where shareholders approved borrowing limits up to Rs 400 Crore. One special resolution passed with 98.05% in favour.
Indo Borax reported robust Q1 FY27 results with 31% revenue growth and 59% PAT growth. Management announced a major acquisition of 64.26% stake in Kronox Lab Sciences to diversify into high-purity specialty chemicals.
Indo Borax reported strong Q1FY27 consolidated performance with Revenue up 31% and PAT up 59% YoY. Strategy focuses on high-margin DOT expansion and the acquisition of Kronox Lab Sciences.
Indo Borax & Chemicals Ltd received a credit rating update from India Ratings, placing its bank loan facilities on 'Rating Watch with Negative Implications'.
Indo Borax & Chemicals Ltd. is relocating its corporate office to a new premises in Andheri (East), Mumbai, effective September 15, 2026.
Indo Borax & Chemicals Limited has announced the acquisition of Kronox Lab Sciences Limited for Rs. 103.22 Crore. The cash deal aims to diversify the company's chemical portfolio.
Indo Borax & Chemicals approved the acquisition of a 64.26% stake in Kronox Lab Sciences for ₹246.12 Crore. The transaction triggers a mandatory open offer for another 25.79%.
Indo Borax & Chemicals Limited issued a postal ballot notice seeking shareholder approval to revise the company's borrowing limits.
Indo Borax & Chemicals Ltd has issued a Postal Ballot notice seeking shareholder approval to increase its borrowing limit to ₹400 Crore.
Indo Borax reported a 59% surge in net profit to Rs 16.25 crore for Q1FY27. The company also announced the amalgamation of its wholly-owned subsidiary.
Indo Borax & Chemicals Ltd reported revenue from operations of ₹70.4 Cr (+31.3% YoY) and net profit of ₹16.3 Cr (+59.8% YoY) for Q1 FY27.
Indo Borax & Chemicals has scheduled a board meeting for August 10, 2026, to consider and approve the unaudited financial results for the quarter ended June 30, 2026.
Indo Borax & Chemicals Limited conducted its 45th Annual General Meeting via video conferencing on July 28, 2026, to transact scheduled business and shareholder resolutions.
India Ratings and Research assigned 'IND BBB+/Stable/IND A2+' ratings to Indo Borax & Chemicals Ltd's bank loan facilities worth ₹60 Crore.
The company submitted its quarterly shareholding pattern for the period ending June 30, 2026, pursuant to SEBI Regulation 31(1)(b).
Indo Borax & Chemicals approved the amalgamation of its wholly owned subsidiary, Indoborax Infrastructure Private Limited. The board also approved shifting the company's registered office.
Indo Borax & Chemicals Ltd. intimated the record date for its 45th AGM and dividend payment. Book closure is from July 22 to 28, 2026.
Indo Borax filed its 45th Annual Report for FY 2025-26, highlighting strong performance. It plans to invest Rs. 20 crore in a new 4,000 MTPA Boron Oxide facility.
Indo Borax & Chemicals Ltd announced grant of 1,688,950 employee stock options under ESOP 2026. The options carry Rs.1 face value per share.
Indo Borax & Chemicals Limited transcript for Q4 and FY26. Management reports significant transformation under new ownership by Zenrock Chemicals, achieving record revenue growth with a focus on operational efficiency and boron chemistry expansion.